Identification of <i>HMGA2</i> as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.
作者:
DOI
10.3389/fonc.2022.981940
PMID
36568239
发布时间
2024-09-09
- 浏览0
Frontiers in oncology
981940页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文